Presentations
Maertens J and Marr K. Presented at ESCMID Global. April 18, 2026; Munich, Germany.
Thanks to the ESCMID technical team for the recording.
Sandison T, et al. Presented at IMARI. January 28-30, 2026; Las Vegas, NV.
Sandison T. Presented at IMARI. January 28-30, 2026; Las Vegas, NV.
Arends SJR, et al. Presented at IDWeek. October 19-22, 2025; Atlanta, GA.
Sandison T, et al. Presented at IDWeek. October 19-22, 2025; Atlanta, GA.
Sandison T, et al. Presented at the Global AMR Innovators Conference (GAMRIC). October 1-3, 2025; London, UK.
Sandison T, et al. Presented at the 12th TIMM conference. September 19-22, 2025; Bilbao, Spain.
Safety and pharmacokinetics of SF001, a next-generation polyene antifungal, following single and multiple doses in healthy adults.
Marr K, et al. Presented at ESCMID Global 2025. April 11-15, 2025; Vienna, Austria.
Efficacy Assessment of SF001, a Next Generation Polyene Antifungal in a Neutropenic Mouse Model of Invasive Fusariosis.
Gebremariam T, et al. Presented at Clinical Mycology Today, the biennial meeting of the MSGERC. September 4-6, 2024; Colorado Springs, CO.
SF001, a Novel Micellar Polyene, Demonstrates a Prolonged Post-antifungal Effect In vitro against Yeast.
Hufnagel D, et al. Presented at ESCMID Global 2024. April 27-30, 2024; Barcelona, Spain.
Inoculum Density has an Impact on SF001 Fungicidal Activity against Candida albicans.
Hufnagel D, et al. Presented at ESCMID Global 2024. April 27-30, 2024; Barcelona, Spain.
Front-Loaded Exposures Increase the Fungicidal Effect of SF001: A Basis for Infrequent Dosing Regimens.
VanScoy BD, et al. Presented at ESCMID Global 2024. April 27-30, 2024; Barcelona, Spain.